|
2018-09-04 |
2018-08-30 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
82 304
-55.6%
27,40
2 255 492 USD
|
82 304
-55.6%
|
27,40
|
2 255 492 USD
|
|
|
2018-08-17 |
2018-08-16 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
1 480
-2.2%
20,08
29 715 USD
|
1 480
-2.2%
|
20,08
|
29 715 USD
|
|
|
2018-08-17 |
2018-08-16 |
VP
Vente planifiée
|
MORATIS GEORGE Z
Global Accounting Officer
Dirigeant
|
695
-3.0%
20,19
14 035 USD
|
695
-3.0%
|
20,19
|
14 035 USD
|
|
|
2018-07-06 |
2018-07-03 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
867
-1.3%
22,47
19 482 USD
|
867
-1.3%
|
22,47
|
19 482 USD
|
|
|
2018-06-08 |
2018-06-08 |
VP
Vente planifiée
|
MORATIS GEORGE Z
Global Accounting Officer
|
455
-2.2%
22,81
10 378 USD
|
455
-2.2%
|
22,81
|
10 378 USD
|
|
|
2017-08-24 |
2017-08-23 |
VP
Vente planifiée
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Administrateur exécutif
|
1 332
-0.7%
23,30
31 036 USD
|
1 332
-0.7%
|
23,30
|
31 036 USD
|
|
|
2017-08-16 |
2017-08-15 |
VP
Vente planifiée
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Administrateur exécutif
|
1 090
-0.5%
24,08
26 247 USD
|
1 090
-0.5%
|
24,08
|
26 247 USD
|
|
|
2017-08-16 |
2017-08-15 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
|
2 350
-4.1%
24,08
56 588 USD
|
2 350
-4.1%
|
24,08
|
56 588 USD
|
|
|
2017-08-16 |
2017-08-15 |
VP
Vente planifiée
|
MORATIS GEORGE Z
Global Accounting Officer
|
770
-4.5%
24,09
18 549 USD
|
770
-4.5%
|
24,09
|
18 549 USD
|
|
|
2017-08-15 |
2017-08-11 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
|
39 357
-40.6%
23,37
919 631 USD
|
39 357
-40.6%
|
23,37
|
919 631 USD
|
|
|
2017-07-05 |
2017-07-01 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
956
-1.6%
24,33
23 259 USD
|
956
-1.6%
|
24,33
|
23 259 USD
|
|
|
2017-06-16 |
2017-06-16 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
|
13 787
-19.1%
22,73
313 379 USD
|
13 787
-19.1%
|
22,73
|
313 379 USD
|
|
|
2017-06-16 |
2017-06-15 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
|
29 160
-33.4%
22,83
665 723 USD
|
29 160
-33.4%
|
22,83
|
665 723 USD
|
|
|
2017-05-30 |
2017-05-25 |
V
Vente
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Administrateur exécutif
|
50 000
-20.1%
22,70
1 135 000 USD
|
50 000
-20.1%
|
22,70
|
1 135 000 USD
|
|
|
2017-05-15 |
2017-05-12 |
V
Vente
|
MORATIS GEORGE Z
Global Accounting Officer
Dirigeant
|
800
-6.0%
21,77
17 419 USD
|
800
-6.0%
|
21,77
|
17 419 USD
|
|
|
2017-05-15 |
2017-05-12 |
V
Vente
|
MORATIS GEORGE Z
Global Accounting Officer
Dirigeant
|
200
-1.5%
21,77
4 354 USD
|
200
-1.5%
|
21,77
|
4 354 USD
|
|
|
2017-05-10 |
2017-05-10 |
V
Vente
|
MORATIS GEORGE Z
Global Accounting Officer
Dirigeant
|
902
-6.3%
21,61
19 492 USD
|
902
-6.3%
|
21,61
|
19 492 USD
|
|
|
2017-02-14 |
2017-01-26 |
V
Vente
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Actionnaire important
|
3 926 068
-42.2%
20,23
79 424 356 USD
|
3 926 068
-42.2%
|
20,23
|
79 424 356 USD
|
|
|
2017-02-14 |
2017-01-26 |
V
Vente
|
WCAS Capital Partners IV, L.P.
Actionnaire important
|
57 488
-42.2%
20,23
1 162 982 USD
|
57 488
-42.2%
|
20,23
|
1 162 982 USD
|
|
|
2017-02-14 |
2017-01-26 |
V
Vente
|
WCAS MANAGEMENT CORP
Actionnaire important
|
3 214
-42.2%
20,23
65 019 USD
|
3 214
-42.2%
|
20,23
|
65 019 USD
|
|
|
2017-02-14 |
2017-01-26 |
V
Vente
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Actionnaire important
|
3 926 068
-42.2%
20,23
79 424 356 USD
|
3 926 068
-42.2%
|
20,23
|
79 424 356 USD
|
|
|
2017-02-14 |
2017-01-26 |
V
Vente
|
WCAS Capital Partners IV, L.P.
Actionnaire important
|
57 488
-42.2%
20,23
1 162 982 USD
|
57 488
-42.2%
|
20,23
|
1 162 982 USD
|
|
|
2017-01-24 |
2017-01-23 |
VP
Vente planifiée
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Administrateur exécutif
|
561
-0.2%
21,79
12 225 USD
|
561
-0.2%
|
21,79
|
12 225 USD
|
|
|
2017-01-24 |
2017-01-20 |
VP
Vente planifiée
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Administrateur exécutif
|
27 965
-10.1%
21,61
604 324 USD
|
27 965
-10.1%
|
21,61
|
604 324 USD
|
|
|
2017-01-19 |
2017-01-19 |
VP
Vente planifiée
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Administrateur exécutif
|
27 969
-10.1%
21,39
598 257 USD
|
27 969
-10.1%
|
21,39
|
598 257 USD
|
|
|
2017-01-19 |
2017-01-18 |
VP
Vente planifiée
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Administrateur exécutif
|
24 329
-8.9%
21,58
525 010 USD
|
24 329
-8.9%
|
21,58
|
525 010 USD
|
|
|
2017-01-19 |
2017-01-17 |
VP
Vente planifiée
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Administrateur exécutif
|
20 000
-7.4%
21,85
436 996 USD
|
20 000
-7.4%
|
21,85
|
436 996 USD
|
|
|
2016-11-18 |
2016-11-16 |
V
Vente
|
WCAS Capital Partners IV, L.P.
Actionnaire important
|
64 674
-32.2%
18,39
1 189 355 USD
|
64 674
-32.2%
|
18,39
|
1 189 355 USD
|
|
|
2016-11-18 |
2016-11-16 |
V
Vente
|
WCAS Capital Partners IV, L.P.
Actionnaire important
|
64 674
-32.2%
18,39
1 189 355 USD
|
64 674
-32.2%
|
18,39
|
1 189 355 USD
|
|
|
2016-11-18 |
2016-11-16 |
V
Vente
|
WCAS MANAGEMENT CORP
Actionnaire important
|
3 616
-32.2%
18,39
66 498 USD
|
3 616
-32.2%
|
18,39
|
66 498 USD
|
|
|
2016-11-18 |
2016-11-16 |
V
Vente
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Actionnaire important
|
4 416 825
-32.2%
18,39
81 225 412 USD
|
4 416 825
-32.2%
|
18,39
|
81 225 412 USD
|
|
|
2016-11-18 |
2016-11-16 |
V
Vente
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Actionnaire important
|
4 416 825
-32.2%
18,39
81 225 412 USD
|
4 416 825
-32.2%
|
18,39
|
81 225 412 USD
|
|
|
2016-07-06 |
2016-07-01 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
943
-2.3%
15,70
14 807 USD
|
943
-2.3%
|
15,70
|
14 807 USD
|
|
|
2016-05-24 |
2016-05-21 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
6 465
-19.5%
11,32
73 184 USD
|
6 465
-19.5%
|
11,32
|
73 184 USD
|
|
|
2016-05-10 |
2016-05-07 |
V
Vente
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
1 702
-11.9%
11,45
19 488 USD
|
1 702
-11.9%
|
11,45
|
19 488 USD
|
|
|
2016-05-10 |
2016-05-07 |
V
Vente
|
MORATIS GEORGE Z
Global Accounting Officer
Dirigeant
|
900
-17.7%
11,40
10 260 USD
|
900
-17.7%
|
11,40
|
10 260 USD
|
|
|
2016-05-05 |
2016-05-05 |
A
Achat
|
FERRER CARLOS A
Administrateur non-exécutif
|
20 000
+50.8%
11,32
226 400 USD
|
20 000
+50.8%
|
11,32
|
226 400 USD
|
|
|
2016-03-07 |
2016-03-07 |
A
Achat
|
FERRER CARLOS A
Administrateur non-exécutif
|
38 942
+8850.5%
12,84
500 015 USD
|
38 942
+8850.5%
|
12,84
|
500 015 USD
|
|
|
2015-11-13 |
2015-11-12 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
20 245
-69.0%
19,31
390 931 USD
|
20 245
-69.0%
|
19,31
|
390 931 USD
|
|
|
2015-11-13 |
2015-11-11 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
21 329
-70.1%
20,07
428 073 USD
|
21 329
-70.1%
|
20,07
|
428 073 USD
|
|
|
2015-08-11 |
2015-08-07 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
1 200
-11.7%
21,76
26 112 USD
|
1 200
-11.7%
|
21,76
|
26 112 USD
|
|
|
2015-08-11 |
2015-08-07 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
40 374
-79.7%
20,99
847 450 USD
|
40 374
-79.7%
|
20,99
|
847 450 USD
|
|
|
2015-07-21 |
2015-07-17 |
V
Vente
|
FERRER CARLOS A
Administrateur non-exécutif
|
3 042
-5.0%
22,37
68 050 USD
|
3 042
-5.0%
|
22,37
|
68 050 USD
|
|
|
2015-07-21 |
2015-07-17 |
V
Vente
|
FERRER CARLOS A
Administrateur non-exécutif
|
83 365
-5.0%
22,37
1 864 875 USD
|
83 365
-5.0%
|
22,37
|
1 864 875 USD
|
|
|
2015-07-17 |
2015-07-17 |
V
Vente
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Actionnaire important
|
467 293
-3.3%
22,60
10 560 822 USD
|
467 293
-3.3%
|
22,60
|
10 560 822 USD
|
|
|
2015-07-17 |
2015-07-17 |
V
Vente
|
WCAS MANAGEMENT CORP
Actionnaire important
|
383
-3.3%
22,60
8 656 USD
|
383
-3.3%
|
22,60
|
8 656 USD
|
|
|
2015-07-17 |
2015-07-17 |
V
Vente
|
WCAS Capital Partners IV, L.P.
Actionnaire important
|
6 842
-3.3%
22,60
154 629 USD
|
6 842
-3.3%
|
22,60
|
154 629 USD
|
|
|
2015-07-17 |
2015-07-17 |
V
Vente
|
WCAS Capital Partners IV, L.P.
Actionnaire important
|
6 842
-3.3%
22,60
154 629 USD
|
6 842
-3.3%
|
22,60
|
154 629 USD
|
|
|
2015-07-17 |
2015-07-17 |
V
Vente
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Actionnaire important
|
467 293
-3.3%
22,60
10 560 822 USD
|
467 293
-3.3%
|
22,60
|
10 560 822 USD
|
|
|
2015-07-15 |
2015-07-13 |
V
Vente
|
FERRER CARLOS A
Administrateur non-exécutif
|
20 279
-25.0%
22,37
453 641 USD
|
20 279
-25.0%
|
22,37
|
453 641 USD
|
|
|
2015-07-15 |
2015-07-13 |
V
Vente
|
FERRER CARLOS A
Administrateur non-exécutif
|
555 769
-25.0%
22,37
12 432 553 USD
|
555 769
-25.0%
|
22,37
|
12 432 553 USD
|
|
|
2015-07-13 |
2015-07-13 |
V
Vente
|
WCAS MANAGEMENT CORP
Actionnaire important
|
2 551
-18.0%
22,60
57 653 USD
|
2 551
-18.0%
|
22,60
|
57 653 USD
|
|
|
2015-07-13 |
2015-07-13 |
V
Vente
|
WCAS Capital Partners IV, L.P.
Actionnaire important
|
45 616
-18.0%
22,60
1 030 922 USD
|
45 616
-18.0%
|
22,60
|
1 030 922 USD
|
|
|
2015-07-13 |
2015-07-13 |
V
Vente
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Actionnaire important
|
3 115 287
-18.0%
22,60
70 405 486 USD
|
3 115 287
-18.0%
|
22,60
|
70 405 486 USD
|
|
|
2015-07-13 |
2015-07-13 |
V
Vente
|
WCAS Capital Partners IV, L.P.
Actionnaire important
|
45 616
-18.0%
22,60
1 030 922 USD
|
45 616
-18.0%
|
22,60
|
1 030 922 USD
|
|
|
2015-07-13 |
2015-07-13 |
V
Vente
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Actionnaire important
|
3 115 287
-18.0%
22,60
70 405 486 USD
|
3 115 287
-18.0%
|
22,60
|
70 405 486 USD
|
|
|
2015-06-29 |
2015-06-29 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
8 848
-96.6%
24,05
212 794 USD
|
8 848
-96.6%
|
24,05
|
212 794 USD
|
|
|
2015-06-29 |
2015-06-26 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
15 300
-98.0%
24,01
367 353 USD
|
15 300
-98.0%
|
24,01
|
367 353 USD
|
|
|
2015-06-29 |
2015-06-25 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
14 841
-98.0%
24,55
364 347 USD
|
14 841
-98.0%
|
24,55
|
364 347 USD
|
|
|
2015-06-24 |
2015-06-24 |
VP
Vente planifiée
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Administrateur exécutif
|
6 459
-2.7%
24,27
156 760 USD
|
6 459
-2.7%
|
24,27
|
156 760 USD
|
|
|
2015-06-24 |
2015-06-24 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
8 034
-96.3%
24,27
194 985 USD
|
8 034
-96.3%
|
24,27
|
194 985 USD
|
|
|
2015-06-24 |
2015-06-23 |
VP
Vente planifiée
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Administrateur exécutif
|
10 668
-4.3%
24,89
265 527 USD
|
10 668
-4.3%
|
24,89
|
265 527 USD
|
|
|
2015-06-24 |
2015-06-23 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
10 711
-97.2%
24,91
266 811 USD
|
10 711
-97.2%
|
24,91
|
266 811 USD
|
|
|
2015-06-24 |
2015-06-22 |
VP
Vente planifiée
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Administrateur exécutif
|
7 210
-3.0%
25,36
182 846 USD
|
7 210
-3.0%
|
25,36
|
182 846 USD
|
|
|
2015-06-24 |
2015-06-22 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
8 639
-96.6%
25,36
219 085 USD
|
8 639
-96.6%
|
25,36
|
219 085 USD
|
|
|
2015-06-23 |
2015-06-19 |
VP
Vente planifiée
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Administrateur exécutif
|
18 165
-7.1%
24,94
453 035 USD
|
18 165
-7.1%
|
24,94
|
453 035 USD
|
|
|
2015-06-18 |
2015-06-18 |
VP
Vente planifiée
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Administrateur exécutif
|
24 900
-11.6%
24,80
617 520 USD
|
24 900
-11.6%
|
24,80
|
617 520 USD
|
|
|
2015-06-18 |
2015-06-17 |
VP
Vente planifiée
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Administrateur exécutif
|
10 109
-4.5%
24,28
245 447 USD
|
10 109
-4.5%
|
24,28
|
245 447 USD
|
|
|
2015-06-05 |
2015-06-03 |
V
Vente
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
13 350
-97.7%
24,57
328 010 USD
|
13 350
-97.7%
|
24,57
|
328 010 USD
|
|
|
2015-02-13 |
2015-02-12 |
V
Vente
|
BRODNAX BRETT
Administrateur non-exécutif
|
5 564
-17.1%
19,73
109 778 USD
|
5 564
-17.1%
|
19,73
|
109 778 USD
|
|
|
2015-02-10 |
2015-02-09 |
V
Vente
|
WCAS MANAGEMENT CORP
Actionnaire important
|
728
-4.9%
18,75
13 650 USD
|
728
-4.9%
|
18,75
|
13 650 USD
|
|
|
2015-02-10 |
2015-02-09 |
V
Vente
|
WCAS Capital Partners IV, L.P.
Actionnaire important
|
13 031
-4.9%
18,75
244 331 USD
|
13 031
-4.9%
|
18,75
|
244 331 USD
|
|
|
2015-02-10 |
2015-02-09 |
V
Vente
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Actionnaire important
|
889 990
-4.9%
18,75
16 687 313 USD
|
889 990
-4.9%
|
18,75
|
16 687 313 USD
|
|
|
2015-02-10 |
2015-02-09 |
V
Vente
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Actionnaire important
|
889 990
-4.9%
18,75
16 687 313 USD
|
889 990
-4.9%
|
18,75
|
16 687 313 USD
|
|
|
2015-02-10 |
2015-02-09 |
V
Vente
|
WCAS Capital Partners IV, L.P.
Actionnaire important
|
13 031
-4.9%
18,75
244 331 USD
|
13 031
-4.9%
|
18,75
|
244 331 USD
|
|
